Litai Intelligent Therapeutics has closed a seed round financing of nearly 50 million RMB.

36Kr learned that on October 10, Litai Intelligent Medicine announced that it has completed a seed round financing of nearly 50 million yuan. This round of financing is jointly invested by iFlytek Venture Capital, L2F Lighthouse Founders' Fund and well-known industrial parties, with Lighthouse Capital acting as the exclusive financial advisor. The funds raised in this round will be mainly used for core pipeline R&D, computing power investment, patent layout, talent recruitment and daily operation.